Latest News and Press Releases

Company’s Part A data readout from first-in-human Phase 1 Trial 1001 in patients with recurrent or refractory metastatic solid tumors known to express GD2, validates GD2-SADA as safe, tolerable and...

PRINCETON, N.J., May 26, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and...

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028" has been added to ...

Dublin, May 14, 2025 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals Market - Products and Applications" report has been added to ResearchAndMarkets.com's offering.The Global Radiopharmaceuticals...

Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The "Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028" report has been added to ...

Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Equipment Market Size, Share and Trends Analysis Report by Type (SPECT, PET, Planar Scintigraphy Systems), Application (Oncology,...

Dublin, June 23, 2023 (GLOBE NEWSWIRE) -- The "Radioligand Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027" report has been added to ...

Dublin, June 20, 2022 (GLOBE NEWSWIRE) -- The "Conjugated Monoclonal Antibodies Global Market Report 2022: By Drugs, By Technology, By Application" report has been added to ResearchAndMarkets.com's...

Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Conjugated Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...

Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha...